Biopartners Holdings AG Purchased by Bioton S.A.
Biopartners is a biotechnology company concentrating on the development of innovative drugs and biopharmaceuticals, where significant market opportunities exist. According to the company, the terms of the deal ensure that all Biopartners' operations remain untouched, with all drug development projects continuing as before under the same management.
Bioton S.A. is a Polish company in the biotechnology sector, manufacturing modern drugs, including recombinant human insulin and its pharmaceutical forms, as well as preparations from the cephalosporine, aminoglycoside and macrolide groups.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.